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Abstract 
In mammals the regulation of genomic instability plays a key role in tumor suppression and 
also controls genome plasticity, which is important for recombination during the processes of 
immunity and meiosis. Most studies to identify regulators of genomic instability have been 
performed in cells in culture or in systems that report on gross rearrangements of the genome, 
yet subtle differences in the level of genomic instability can contribute to whole organism 
phenotypes such as tumour predisposition. Here we performed a genome-wide association 
study in a population of 1379 outbred Crl:CFW(SW)-US_P08 mice to dissect the genetic 
landscape of micronucleus formation, a biomarker of chromosomal breaks, whole 
chromosome loss, and extra-nuclear DNA. Variation in micronucleus levels is a complex trait 
with a genome-wide heritability of 53.1%. We identify seven loci influencing micronucleus 
formation (false discovery rate<5%), and define candidate genes at each locus. Intriguingly at 
several loci we find evidence for sex-specific genetic effects in micronucleus formation, with 
a locus on chromosome 11 being specific to males.  
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Introduction 
Genomic instability is a key hallmark of nearly all cancer cells (Hanahan and Weinberg 
2011), and patients carrying loss-of-function mutations in components of the DNA damage 
response (DDR) machinery, including BRCA1, BRCA2, ATM, BUB1 and RAD51, are highly 
predisposed to tumorigenesis due to a significant increase in their basal somatic mutation rate 
(Watson et al. 2013). First-degree relatives of mutation carriers have also been shown to have 
a higher cancer incidence, suggesting that the link between mutations in DDR genes and 
cancer is heritable. In the general population, genomic instability has been linked to tumor 
incidence, higher levels of genomic instability being associated with malignancies such as 
lung and prostate cancer, and tumours of the skin and brain (Bonassi et al. 2011; Forsberg et 
al. 2014). Furthermore, sequencing and genome-wide association studies have linked variants 
in DNA repair genes such as CHEK2, ATM, RAD50, BRIP1 and PALB2 with breast cancer 
disease risk (Rahman 2014), highlighting the importance of DNA repair in tumor 
predisposition. In the same way, genes that regulate cell division and chromosome 
segregation also prevent genomic instability, and their mutation has been linked to 
tumorigenesis (Godinho and Pellman 2014; Lee 2014). Micronuclei have also been linked to 
chromothripsis (Zhang et al. 2015), the phenomenon by which up to thousands of clustered 
chromosomal rearrangements occur in a single event in localised and confined genomic 
regions. 
               One test to assess genomic instability in vivo is the micronucleus assay (Evans et al. 
1959), which enumerates the number of peripheral erythrocytes that carry DNA. Since the 
nucleus is expelled during erythropoiesis, the presence of micronuclei in these cells is easily 
quantified and indicates that DNA damage occurred prior to enucleation. The frequency of 
micronucleated cells indicates the basal level of somatic genomic instability. However, it is 
unknown whether the presence and extent of micronuclei are heritable traits, and therefore 
under genetic control. Understanding their genetic architecture may therefore indicate 
pathways by which genetic instability and cancer arise.  
 
! 4!
               To identify genetic mediators of micronucleus formation in vivo we used an outbred 
mouse population. Performing these studies in the mouse has several distinct advantages: 
Firstly, in mice, micronucleated erythrocytes are not removed by the spleen meaning that 
micronucleus formation can be measured with high sensitivity and accuracy (Balmus et al. 
2015). In humans these cells are rapidly cleared from the circulation. Secondly, functional 
studies can be followed up in the mouse by use of knockout or clustered regularly-interspaced 
short palindromic repeats (CRISPR) technology (Wang et al. 2013), and thus candidate causal 
variants/genes can be assessed in vivo. Lastly, since multiple aspects of whole animal 
physiology, such as metabolism and endocrine function, may influence micronucleus 
formation we can also look for the contribution of these factors to micronucleus levels, which 
is not possible using in vivo culture systems.  
Genetic mapping in the mouse using conventional crosses suffers from poor resolution, which 
presents a challenge when trying to identify the causal genes (Yalcin et al. 2010). To 
circumvent this issue we used a Swiss Webster outbred stock Crl:CFW(SW)-US_P08 
(hereafter CFW) more suited to high-resolution mapping. This stock carries a limited number 
of segregating alleles at each locus, and a large number of recombination events leading to 
rapid linkage disequilibrium decay (Yalcin et al. 2010). We measured micronucleus levels 
and genotypes in 1379 CFW mice that were part of a larger multi-phenotype study (Nicod et 
al., 2016), and for which genotypes were already available, to show that this is a heritable 
polygenic trait. We map numerous associated quantitative trait loci (QTL) and identify 
potential causal genes, as a prelude to further functional investigation.  
 
Methods 
 
Study animals and phenotyping 
All mice (Crl:CFW(SW)-US_P08) were purchased from Charles River, Portage, USA at 4-7 
weeks of age and shipped to MRC Harwell, Oxfordshire, UK. Mice were housed in IVC 
cages (three per cage) on an ad-lib diet and at 16 weeks of age started a 4-weeks phenotyping 
pipeline where behavioural and physiological measures were collected. This phenotyping 
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pipeline and the data collected is described elsewhere (Nicod et al., 2016). At 20 weeks of 
age mice were weighed and sacrificed between 8 am and 12 pm, after overnight food 
restriction, and blood was collected by cardiac puncture into EDTA-coated vials. Full blood 
count analysis was performed with a Siemens Advia 2120 hematology analyzer using 200 µl 
of whole blood. In parallel a 50 µl aliquot of whole blood was collected into heparin solution, 
fixed in ice-cold methanol and stored at -80°C until micronucleus levels were measured by 
flow cytometry as described previously (Balmus et al. 2015). 
Analysis of micronucleus levels was performed using the R statistical analysis software 
package using purpose-written software available on request from the authors. Outliers, 
defined as data points that were more than three standard deviations from the mean, were 
excluded. The effects of covariates such as sex, body weight and batch on micronucleus level 
were assessed by ANOVA, with each explaining more than 1% of the variance at a significant 
level (P<0.05) being included in a linear regression model from which residual measures 
were obtained. The linear model used for the micronucleus measure was the following: 
Micronucleus_level ~ 1 + Sex + (1|Batch) + Year_of_measure. The residuals were quantile-
normalised and used for genome-wide association testing. For the sex-specific genome-wide 
association testing, sex was omitted from the covariates in the modelling of the micronucleus 
measure.  
 
 
 
 
Studies in knockout lines 
We analysed knockouts for the genes Trex1, Nfkbil1, Trub2 and H2-Eb1 (Trex1tm1(KOMP)Wtsi, 
Nfkbil1tm1a(KOMP)Wtsi, Trub2tm2a(EUCOMM)Wtsi, and H2-Eb1tm1a(KOMP)Wtsi) coming from the Sanger 
Mouse Genetics Project (White et al., 2013). Blood from these animals was collected at 16 
weeks and analysed as previously described (Balmus et al. 2015). 
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Sequencing, variant calling and genotype imputation 
Nicod et al., 2016 provides full details of the sequencing and genotyping protocol deployed in 
this study. In summary, DNA was extracted from tissues collected at the time of sacrifice. 
Sequencing libraries of 95 barcoded DNA samples were pooled and 100bp paired-end 
sequencing reads were generated, using one lane of a HiSeq (Illumina), per pool yielding 30 
Gb of sequence data. Reads were mapped to the mouse mm10 reference genome and variants 
called using all chromosomes pooled together. Imputation of genotype probabilities was 
performed using STITCH, (Davies et al 2016) which models the chromosomes in the CFW 
mice as mosaics of a limited number of founder haplotypes. Optimization showed that the 
most probable number of founder haplotypes was 4. The catalogue of segregating variation in 
the CFW was derived from a ~370X pileup of all mice, combined with the positions of 
known SNPs in the Mouse Genomes Project (Keane et al., 2011). We identified 7,073,398 
SNPs in this way, at which we imputed genotype dosages using STITCH (Davies et al 2016). 
After stringent post-imputation quality control we retained 5,766,828 high-quality imputed 
SNPs for subsequent analysis. We used two quality control measures on selecting well 
imputed versus poorly imputed SNPs: the P-value for violation of Hardy-Weinberg 
equilibrium P-value and IMPUTE2-style INFO scores, as described previously (Howie et al. 
2009). The mean SNP-wise correlation (r2) with sites that were also polymorphic on a 
genotyping microarray (Yang et al., 2009) using 44 samples was 0.974 before QC and 0.981 
after QC. 
 
Genome-wide association study 
Details of QTL mapping are fully described in (Nicod et al., 2016). In brief, we identified a 
subset of 359,559 SNPs tagging the entire genome and used the imputed allele dosages at 
these loci to compute the genome-wide additive genetic relationship matrix (GRM). We 
tested for the association between each tagging SNP (represented by its imputed dosage) and 
the quantile-normalized residuals of the micronucleus and hematological measures as fixed 
effect in a mixed-model, controlling for relatedness and population structure using a GRM as 
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random effect. We used a leave-one chromosome-out strategy in which the GRM used to test 
association of SNPs on a given chromosome was computed from all other autosomes. 
Statistical significance at each locus was measured by ANOVA, comparing the fit of the 
allele dosage model to the null model. We estimated the FDR by permutation and called 
QTLs when at least one SNP had an FDR<5%. After the discovery phase using the 360k 
tagging SNPs, the genetic analysis was repeated in a 20Mb window around the mapped QTLs 
using the complete set of SNPs, to determine confidence intervals at each QTL using a logP-
drop method. The same analysis was repeated testing males and females separately. We next 
tested for gene-by-sex interaction at all QTLs detected with all mice (males and females). 
Significance of the interaction effect at the QTL was determined by ANOVA, comparing the 
fit of the interaction model between sex and the dosage at the most strongly associated SNP 
(pheno~geno*sex) to the direct additive effect model (pheno~geno+sex). 
 
 
Variant Functional Annotations  
Putative SNPs were annotated using ANNOVAR (Wang et al. 2010) with gene 
annotations/proteins from the UCSC mouse genome annotation database (mouse assembly 
GRCm38/mm10). Unless otherwise stated, version 73 of the Ensembl mouse genome 
annotation database (assembly GRCm38/mm10) and software were used. 
 
All SNPs 
For each SNP position, its GERP sequence conservation score (Pollard et al. 2010) was 
obtained from the Ensembl Compara database based on the alignments of 36 Eutherian 
mammals (from the EPO whole-genome multiple alignment pipeline [ref 
http://sep2013.archive.ensembl.org/info/genome/compara/epo_anchors_info.html]). A score 
for sequence constraint was also reported derived from stretches of the local, multiple 
alignment around each SNP [ref 
http://sep2013.archive.ensembl.org/info/genome/compara/analyses.html#conservation]. 
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Both coding and non-coding sequence nucleotide variants (SNVs) were analyzed using the 
Ensembl Variant Effect Predictor (VEP) (Yourshaw et al. 2015). For coding SNPs, SIFT (Ng 
and Henikoff 2003) was used to predict whether an amino acid substitution affects protein 
function, based on sequence homology and the physical properties of amino acids. Using 
transcription factor binding site data [ref 
http://sep2013.archive.ensembl.org/Mus_musculus/Experiment/Sources?db=funcgen;ex=all;f
db=funcgen;r=17:46617590-46621119#ExperimentalMetaData], non-coding SNPs were 
assessed for potential disruption of binding sites. 
 
Coding SNPs 
A more detailed analysis to that performed for all the SNPs was performed for non-
synonymous SNPs predicted by ANNOVAR. GERP (Pollard et al. 2010) and sequence 
conservation scores were obtained as described previously (Yang and Wang 2015). In 
addition, text-based alignments were obtained from Ensembl EPO alignments of 13 eutherian 
mammals (Yates et al. 2016). A region of ten nucleotides up- and down-stream for each SNP 
was specified, and the alignments across all potential 13 mammals was extracted for this 21 
nucleotides region. Not all local regions had an alignment as some were unique to mouse. 
With respect to protein-based analyses, VEP was configured to report whether a coding SNP 
lay within a protein domain. As before SIFT consequences (Ng and Henikoff 2003) were 
reported for each SNP, if available. In the case of multiple SNP predictions for a single SNP, 
the most deleterious prediction (lowest score) was reported. 
In addition the effects of the amino acid change were assessed using the Grantham matrix 
(Grantham 1974). SNPs causing amino acid changes were classified by their Grantham scores 
as follows. A SNP was classified as 'conservative' for a Grantham score of less than 60. A 
score greater than 60 but less than 100 was classified as 'non-conservative'. A SNP was 
classified as 'radical' for scores equal to or greater than 100. 
To obtain text-based protein alignments around a SNP, the following strategy was used. The 
ANNOVAR SNPs were predicted using UCSC protein data, identified using UCSC gene 
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identifiers. These UCSC gene identifiers were first used to link to Ensembl mouse transcript 
identifiers and then to Ensembl gene identifiers. The Ensembl gene identifiers were used to 
query the Ensembl Compara database for protein alignments across seven species; human, rat, 
dog, chicken, pig, cow and platypus. 
For computational efficiency the Ensembl Compara software pipeline selects a single (usually 
canonical) transcript for each gene on which to compute homologies across species. 
Similarity is determined by aligning protein alignments of genes. Therefore, for genes that 
have multiple translations, features of interest can occur in transcripts from which it is not 
possible to determine their context in terms of homology via Ensembl. This is the case here 
for coding SNPs reported by ANNOVAR. The set of UCSC proteins used included proteins 
that were not considered the canonical transcript by Ensembl and upon which homologies 
were computed. Hence for ANNOVAR, predicted coding SNPs reported on a transcript not 
pre-computed in Ensembl, these were reported as 
'UCSC_protein_not_used_for_homology_in_Ensembl'. Also there can be examples where the 
gene in which the SNP lies has no sequence homology to another species; these were tagged 
as 'no_mouse_sequence_in_Ensembl_homology'. 
For UCSC-based SNPs present in the Ensembl Compara database (Yates et al. 2016) the site 
of the amino acid was used to create an expanded peptide sequence of four amino acids up- 
and down-stream of the mutated site. This gave a nine amino acid sequence to match against 
alignments from other species. This sequence was shortened appropriately if the SNP site was 
close to the start or end of the protein in which it lay. The localized protein alignments were 
reported in text format for the seven species as listed previously. 
 
Analysis of micronuclei in TREX1 wildtype and mutant cells.  
RPE-1 derived cell lines were constructed as described previously (Maciejowski et al. 2015). 
Cells were plated onto 35 mm glass bottom dishes (MatTek) 48 h before imaging. One hour 
before imaging cell culture media was replaced with phenol red-free DMEM/F12 medium. 
Live cell imaging was performed using a CellVoyager CV1000 spinning disk confocal system 
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(Yokogawa, Olympus) equipped with 445, 488, and 561 nm lasers, a Hamamatsu 512 x 512 
EMCCD camera. Pinhole size was 50 µm. Images were acquired at the indicated intervals 
using a UPlanSApo 60x/1.3 silicone oil objective with the correction collar set to 0.17. The 
pixel size in the image was 0.27 µm. The 617/73 emission filter was used for image 
acquisition of mCherry-tagged proteins. Sixteen µm z-stacks were collected at 2.0 µm steps. 
Temperature was maintained at 37ºC in a temperature-controlled enclosure with CO2 support. 
Maximum intensity projection of z-stacks and adjustment of brightness and contrast were 
performed using Fiji software. Image stitching was done with the Fiji plugin Grid/Collection 
stitching (Preibisch et al. 2009) with 20% tile overlap, linear blending, a 0.30 regression 
threshold, a 2.50 max/avg. displacement threshold, and a 3.50 absolute displacement 
threshold. Images were cropped and assembled into figures using Photoshop CS5.1 (Adobe). 
Evaluated for statistical significance using ANOVA and Kruskal-Wallis post hoc test. 
 
Ethics Statement 
The work described here was approved by the Oxford local ethics committee and was 
performed in accordance with Home Office Regulations, UK. A detailed description of the 
procedures is provided in Nicod et al., 2016.  
 
Results 
Strain specific and sex differences in micronucleus levels 
To determine whether genetic diversity drives differences in micronucleus levels in mice, we 
first analyzed males from four inbred strains (Fig. 1A) finding significant differences in 
micronucleus levels between strains (BALB/cJ>C57BL/6NTACCBA/2J>129S5SvEvBrd; 
P<0.05; one-way analysis of variance (ANOVA)). Micronucleus levels were sexually 
dimorphic (Fig. 1B), with females of two C57BL/6 substrains (C57BL/6J and C57BL/6c-/c-[!
C57BL/6)TyrC)Brd]) and 129S5SvEvBrd showing significantly lower micronucleus levels than 
male littermates (P<0.00001; Student’s two-tailed t-test).  
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Genetic mapping in outbred mice 
We provide a detailed description and characterization of the CFW mouse population used in 
this study in (Nicod et al., 2016). To map loci linked to micronucleus formation in the CFW 
we used a highly sensitive and reproducible high-throughput flow-cytometric micronucleus 
assay to score the frequency of micronucleated erythrocytes in blood obtained from 1,485 
unrelated CFW animals (733 males and 752 females) aged 20 weeks of age (Balmus et al. 
2015). Initial analysis revealed micronucleus levels to be approximately normally distributed 
(Figure S1). Body weight and a full haematological profile were also measured at the time of 
blood collection. DNA was obtained from 1,379 of these mice (677 males and 702 females) 
and, following sparse whole-genome sequencing at an average coverage of 0.15X (range 
0.06X to 0.51X), genotype probabilities imputed at 7,073,398 single-nucleotide 
polymorphisms (SNPs) segregating within this population (Nicod et al., 2016). For the 
genetic analysis we retained 5,766,828 SNPs that passed a stringent post-imputation quality 
control threshold (Impute2-like INFO score > 0.4 and (in autosomes only) P-value for Hardy-
Weinberg equilibrium R2>1×10-6).   
To map quantitative trait loci (QTL) we used a subset of 359,559 SNPs tagging all other 
SNPs with a minor allele frequency (MAF)>0.1% at LD R2 > 0.98, thereby capturing the 
common genetic variability present in this population. The heritability of micronucleus levels 
in the CFW, as estimated from the additive genetic relationship matrix (GRM) based on these 
tagging SNPs, was 53.1% (se 7.7%) (Nicod et al., 2016). Genetic mapping was performed 
using a mixed-model by testing the association of each tagging SNP as a fixed effect with the 
level of micronuclei, using the same GRM as a random effect, and controlling for relevant 
covariates (see Methods and Nicod et al., 2016). This genome-wide analysis revealed seven 
QTLs at a false discovery rate (FDR) < 5%. (Fig. 1C & 1D). We then repeated the genetic 
analysis around each QTL using all nearby SNPs from the total catalogue of 5,766,828, to 
fine-map and determine the confidence interval (CI) at each locus (see Methods).  
! 12!
Table 1 shows a summary of the seven loci identified and their 95% CI, with sizes ranging 
from 476Kb to 1.46Mb (mean 905Kb). In total, the 95% CI include 197 coding genes, or an 
average of 28 genes identified at each QTL. The most significant locus was on chromosome 8 
with a –log10 P-value of 13.05 (Table 1). At this locus the most significant SNP fell next to 
the Werner syndrome Wrn gene. WRN is a RecQ helicase having intrinsic 3’ to 5’ DNA 
helicase activity (Gray et al. 1997; Shen and Loeb 2000). It interacts with Ku70/80, and 
participates in DNA end processing. Defects in WRN are associated with premature ageing, 
chromosomal instability, and tumorigenesis (Shen and Loeb 2000). Candidates at other loci 
include Trp53, Rassf3, and Trub2, all of which have established roles in the regulation of 
DNA repair/genomic stability (Smith and Fornace 1995; Zucchini et al. 2003; van der 
Weyden and Adams 2007), Fig. 2 & Fig. 3).  
Interestingly, after correcting for the effect of potential confounding variables (see Methods), 
we found small but highly significant positive correlations between micronucleus level and 
several haematological measures; the red blood cells distribution width (RDW, P = 2.55×10-
26,Spearman  R2 = 0.1), the hemoglobin concentration distribution width (HDW, P = 1.63×10-
12, R2 = 0.04, Spearman), the mean cellular hemoglobin concentration (CHCM, P = 3.14×10-
11, R2 = 0.04, Spearman), and the measure of blood hemoglobin (measHGB, P = 1.88×10-6, 
R2 = 0.02, Spearman). Elevation of RDW, which is a measure of the variance of red blood 
cell width, often occurs together with elevated HDW, which measures the variation in 
hemoglobin content of red blood cells. For example, iron deficiency may cause a reduction in 
hemoglobin production (elevated HDW), which causes smaller red blood cells (elevated 
RDW). Elevation of RDW and/or HDW is a characteristic of anemia, a condition that may be 
caused by genomic instability (O’Driscoll 2012), and mouse models of genome instability 
disorders often display hematological abnormalities (Gallagher et al., 2011; with Crossan et 
al., 2011; with Nijnik et al., 2012). With this in mind we performed a genetic analysis with 
these hematological measures and discovered that measHGB and CHCM are both associated 
with the same locus on chromosome 5 (P = 3.67x10-7 and 5.05x10-7, respectively [Figure 
S2]). We also mapped a micronucleus QTL at this locus, that contains only three genes within 
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its 95% CI, including Slc7a1. Mice carrying a homozygous deleterious mutation of this gene 
die of anemia at birth with 50% fewer red blood cells and reduced hemoglobin levels (Perkins 
et al. 1997). Hence Slc7a1 is a potential causative gene for the hematological traits and with a 
potential indirect effect on micronucleus levels.  However, another gene within the QTL is the 
Microtubule Associated Tumor Suppressor Candidate 2 (Mtus2) (Jiang et al. 2009), which 
has been implicated in the function of the microtubule cytoskeleton (Ward et al. 2013). 
 
Erythropoietic micronucleus formation and sex  
Consistent with our observation of differences between sexes in micronucleus levels, genetic 
mapping performed on each sex independently revealed that, when applying the same 
FDR<5% threshold for QTL discovery, two loci (on Chrs 10 and 17) were detected only in 
females and one, on Chr 11, only in males (Fig. 1C). We tested for gene-by-sex interactions 
at all QTLs using the entire dataset and found that the locus on chromosome 11 shows a sex-
specific effect on micronucleus formation in male mice (ANOVA P=3.13×10-4). The QTL on 
Chr 8 is present in both sexes while the QTLs on chromosomes 2, 5 and 9 do not reach 
genome-wide significance (FDR<5%) when males and females are tested separately, 
presumably due to a lack of power (Fig. 1D).  
 
Identification of candidate genes at QTL 
Gene ontology (GO) analysis revealed four genes under the micronucleus QTLs (Table S1) 
with annotations associated with DNA repair; Wrn, Hspa1b,! Hspa1a and Hspa1l (GO 
0006281). Other genes such as Aurora kinase B (Aurkb) have established roles in the 
regulation of processes such as the cell cycle (Adams et al. 2001), and links to processes such 
as mitosis, which might be expected to also result in elevated levels of micronuclei if 
dysregulated.  
Our genotyping by low-coverage sequencing methodology means we have identified most 
high-frequency SNPs segregating in the CFW, and can test them for association with the trait, 
opening up the possibility of identifying functional variant(s) at each QTL. From our set of 
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5,766,828 SNPs we annotated all variants in the 95% CI at each QTL provided they had a P-
value of association with micronucleus levels < 10-3, to ascertain if they could disrupt gene 
function, and hence contribute to elevated micronucleus levels. We used a combination of 
approaches, annotating variants with ANNOVAR, applying GERP scores, Grantham and 
SIFT analysis, and also by using the Ensembl variant effector predictor (VEP) from Ensembl 
(McCarthy et al. 2014). Table 2 shows a list of the top five scoring SNPs at each locus 
ranked by P-value; at some loci there were fewer than five or no coding SNPs that could be 
scored in this way.  
We found missense variants with strong predicted deleterious effects in the Wrn, Atrip, Trex1 
and Aurkb genes, which, as noted above, have annotated roles in the regulation of genomic 
stability making these variants high value candidates. For Aurkb the SNP identified 
(rs29417126) results in a F45S change, and falls into a highly conserved region of the protein 
(Fig. 4). We projected this position onto the human AURKB protein revealing that it falls into 
a residue previously found to be post-translationally modified/phosphorylated (Daub et al. 
2008). Indeed, this position has been found to be mitotically phosphorylated, and thus is 
likely to play a regulatory role in AURKB function. Thus Aurkb is a likely gene responsible 
for the association at the QTL on chromosome 11. Importantly this QTL also includes the 
gene Trp53, which is involved in the cellular response to DNA repair, and thus is another 
potential candidate at this locus. However, we did not identify any missense coding variant on 
the Trp53 gene in the CFW, an observation in line with the absence of variants in the classical 
inbred strains (Keane et al. 2011). However, it is possible that a causal regulatory variant that 
controls expression of Trp53 may yet be identified.  
 
We next took advantage of both published and novel mouse knockout data to study genes 
within our QTL intervals. Over 1800 mammalian phenotype (MP) terms have been assigned 
to the 197 genes within the QTLs, including some associated with genomic instability, 
spindle abnormalities and defects in replication (Table S1). For many of the genes, 
phenotypes/functions associated with genomic instability have been assigned (Table S2). We 
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then attempted to predict genes associated with elevated levels of micronuclei. To do this we 
searched for live mice generated by the Wellcome Trust Sanger Mouse Genetics Project 
(White et al., 2013). This analysis revealed four strains (Trex1, Nfkbil1, Trub2 and H2-Eb1) 
available for testing using the micronucleus assay. Our analysis of potentially pathogenic 
variants within QTLs (Table 2) revealed a non-synonymous change within Trex1 (R269G; 
rs386972414) as a candidate variant. TREX1 is a major 3’-5’ DNA exonuclease linked to 
systemic lupus erythematosus and also Aicardi-Goutières syndrome (Fauré et al. 1999; Crow 
et al. 2000). Analysis of blood from Trex1+/- and Trex1-/- mice revealed significantly elevated 
levels of DNA positive red blood cells, making this gene a strong candidate at this locus (Fig. 
2 and Fig. 4). The micronucleated erythrocyte frequency for Nfkbil1, Trub2 and H2-Eb1 
mutants was not significantly different to that of wildtype control mice (Figure S3). 
 
The identification of elevated levels of micronuclei in Trex1 mice was unexpected given the 
role of this gene in single-stranded DNA processing but not directly in DNA repair or 
chromosome segregation. We next used time lapse microscopy of micronuclei in isogenic 
human cell lines (RPE-1) in which chromatin (H2B) was labelled with mCherry in the context 
of TREX1 disruption, and in a matched control (TREX1 wildtype) line (Fig. 4). Analysis of 
808 cell divisions from TREX1 mutant cells and 405 from wildtype cells revealed no 
difference in the frequency of large micronuclei, a result in keeping with the observation that 
Trex1 mutant mice do not show elevated levels of spontaneous mutation in the Big Blue assay 
(Morita et al. 2004). We conjecture that the elevated frequency of RBCs staining with 
propidium iodide may be the result of the accumulation of single-stranded DNA fragments 
previously reported to accumulate in tissues from Trex1 mutants (Morita et al. 2004), rather 
than bulky micronuclei resulting from chromosomal breaks or whole chromosome loss. This 
suggests that the micronucleus assay used here is capable of identifying genes with a range of 
DNA processes functions beyond those involved in DNA repair/chromosome segregation. It 
is important to note that Trex1 abuts Atrip, a known DNA repair gene, and we cannot exclude 
an indirect effect of the targeting event on Atrip gene function.  
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Discussion 
          We report an in vivo genetic screen for mediators of micronucleus formation and 
identify seven loci that reach genome-wide significance. At these loci we mapped genes that 
have established roles in DNA repair or the regulation of the cell cycle, and we annotated 
variants at these loci to identify possible candidates associated with elevated micronucleus 
levels. One locus also affects two haematological measures and contains a gene (Slc7a1) 
causing severe anaemia in the mouse. Further, functional evidence in vivo in a mouse mutant 
supports the role of Trex1 in the formation of extra-nuclear DNA.  
 
We found evidence for a role of sex in the formation of micronuclei, with a locus on 
chromosome 11 containing the Aurkb gene being male-specific. In the case of erythrocyte 
micronucleus levels it seems unlikely that this phenotype is mediated by sex hormones or 
anatomical differences between male and female mice, although these factors could possibly 
contribute. Interestingly, men have a higher incidence of and mortality rate from sex-
unspecific cancers, a fact that is unexplained by known risk factors (Cook et al. 2011; Edgren 
et al. 2012). Recently, mosaic loss of the chromosome Y in peripheral blood cells, which 
indicates loss of Y in hematopoietic progenitor cells, was associated with reduced survival 
and a higher risk of cancer in men (Forsberg et al. 2014). In CFW mice we found elevated 
micronucleus levels in males and find a sex-specific locus controlling this trait, further 
highlighting the role of sex in predisposition to tumorigenesis.  
 
What might explain the differences in micronucleus levels in male and female mice that we 
observed? It has previously been shown that the regulatory genome is sexually dimorphic 
(Yang et al. 2006) with as many as 70% of transcripts showing sex-specific differences in 
expression (Yang et al. 2006), and recent work has shown that the expression of several DNA 
repair proteins is influenced by sex. Sexually dimorphic regulation of DNA repair genes 
could have evolved to support processes such as meiosis, which is regulated differently 
! 17!
between the sexes (Morelli and Cohen 2005). In addition to the locus on chromosome 11 six 
other loci containing both known and novel candidate DNA repair genes were identified. It is 
important to note that while micronuclei are a marker of genomic instability they also 
measure the genotoxic effects of disease processes. For example, micronuclei are elevated in 
autoimmune disorders such as systemic lupus erythematosus and thus may be associated with 
other traits/phenotypes defined in this outbred population (Al-Rawi et al. 2014). Future 
studies will involve validating candidate variants at these loci, for example using CRISPR-
mediated gene editing. 
 
Collectively, this work reveals the landscape of micronucleus formation in the mouse and the 
value of studying traits in an outbred mouse population, and at the whole organism level.  
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Data availability 
The data and the results of the analysis described in this paper are available in an open access 
database at http://outbredmice.org. Mapping results can be visualised at 
http://mus.well.ox.ac.uk/gscandb/ (GScanViewer). 
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Legends to Figure 
 
Figure 1: Micronucleus levels are genetically controlled. A). Graph shows the percentage 
of micronucleated (MN) normochromatic erythrocytes (NCE) in males from four different 
inbred strains of mice. Boxplot shows the median and the min-max (whiskers) of at least six 
measurements for each strain. Data were analysed by one-way analysis of variance 
(P<0.0001) followed by Tukey’s post hoc test (P<0.05 for all combinations except 
C57BL/6NTAC and CBA/2J). B). Micronucleus levels are influenced by sex in mice. Shown 
is the difference in micronucleus levels in males (blue) and females (pink) for three strains of 
inbred laboratory mice. Data were analysed by unpaired Student’s two-tailed t-test, 
P<0.00001. C). Manhattan plots of genome-wide analyses for micronucleus levels performed 
in all mice (top) or in female (middle) or male (bottom) mice only using the subset of tagging 
SNPs (n=359,559).  Horizontal red lines represent –log10 P-values at which QTLs reach FDR 
< 5%. D). QTLs detected in all mice, males and females. Loci with FDR<5% are shaded in 
grey. These QTL positions were defined using the abovementioned 359,559 tagging SNPs.  
 
Figure 2: Genome-wide significant loci for micronuclei on Chromosomes 2, 5, 8 and 9. 
The −log10 P-values of imputed single-nucleotide polymorphisms (SNPs) associated with 
micronucleus levels are shown on the Y axis. The X axis gives chromosome and position in 
megabases (Mb).  Genes within the regions are shown in the bottom panels (for clarity, as 
indicated on the figure, some gene names have been omitted). Linkage disequilibrium of each 
SNP with top SNP, shown in large purple diamond, is indicated by its colour. The plots were 
drawn using LocusZoom (Pruim et al. 2010). 
 
Figure 3: Genome-wide significant loci for micronuclei on Chromosomes 10, 11 and 17. 
The −log10 P-values of imputed SNPs associated with micronucleus levels are shown on the 
left y axis. The horizontal axis gives chromosome and position in megabases (Mb).  Genes 
within the regions are shown in the bottom panels (for clarity, as indicated on the figure, some 
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gene names have been omitted). Linkage disequilibrium of each SNP with top SNP, shown in 
large purple diamond, is indicated by its colour. The plots were drawn using LocusZoom 
(Pruim et al. 2010). 
 
Figure 4: Candidate genes from genome-wide significant loci. A). Frequency of propidium 
iodide positive, micronucleated (MN) normochromatic erythrocytes (NCE) in wildtype (+/+), 
heterozygote (tm1/+) and homozygous (tm/tm) Trex1 knockout male mice. Each circle, 
square or triangle indicates an individual mouse. Mutant mice had significantly elevated MN-
NCE when compared to wild-type control mice (Student’s two-tailed t-test; P<0.0001), but 
heterozygote and homozygote mice showed comparable levels of MN-NCE. B & C). 
Micronucleus formation in human TREX1 null and wildtype control cells. Chromatin was 
labelled with H2B- mCherry. The data shown is the result of three independent experiments 
where >100 mitoses were counted. Cell lines 2.2 and 2.5 are TREX1 null RPE-1 cells. For a 
full description of the lines used in these experiments see Maciejowski et al. 2015. Wildtype 
(WT) refers to an isogenic control. D). Schematic to show alignment of mouse and human 
AURKB proteins. A candidate sequence nucleotide polymorphism (SNP) in Aurkb 
(rs29417126) falls into a highly conserved residue of AURKB that is known to be mitotically 
phosphorylated and to regulate the cell cycle.  
 
Table 1: Genome-wide significant loci. Shown are the seven genome-wide significant loci 
for micronucleus levels and the genes within the 95% confidence intervals. The start and end 
positions of each QTL are provided, and the minor allele frequency (MAF), beta and effect 
size (variance explained) of the top scoring SNP. These QTL positions were defined using the 
entire collection of SNPs for higher mapping resolution.  
 
Table 2: Pathogenicity analysis of variants at loci associated with elevated micronucleus 
levels. Shown are the top five scoring variants at each of the seven genome-wide significant 
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loci ranked by –log10 P-value. See Methods for a description of the approach used for variant 
annotation.  
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Table&1:&Genome-wide&significant&loci.&
Chromosome Top SNP position Top SNP logP FDR Size 95% Confidence Interval (bp) Start position 95% CI End position 95% CI Number of genes in 95% CI Gene names MAF beta
Variance 
explained 
(%)
2 29990674 5.21 0.017 661130 29606566 30267695 20 Rapgef1,Gm13547,Trub2,Coq4,Slc27a4,Urm1,Cercam,Odf2,Gle1,Sptan1,Wdr34,Set,Pkn3,Zdhhc12,Zer1,Tbc1d13,Endog,D2Wsu81e,Ccbl1,Lrrc8a 0.49 0.33 1.29
5 148761610 4.66 0.045 747871 148093705 148841575 3 Mtus2,Slc7a1,Ubl3 0.46 0.27 1.13
8 33158129 13.05 0 1312071 32889539 34201609 13 Wrn,Purg,Tex15,Ppp2cb,Ubxn8,Gsr,Gtf2e2,Smim18,Rbpms,Dctn6,Mboat4,Leprotl1,Saraf 0.38 0.59 4.46
9 109076890 5.43 0.015 624542 108855860 109480401 20 Slc26a6,Tmem89,Uqcrc1,Col7a1,Ucn2,Pfkfb4,Shisa5,Trex1,Atrip,Tma7,Ccdc51,Plxnb1,Fbxw21,Fbxw13,Fbxw20,Fbxw14,Fbxw14,Fbxw22,Fbxw16,Fbxw19 0.20 0.46 1.77
10 121477912 8.55 0 476002 121229924 121705925 6 Tbc1d30,Gns,Rassf3,Tbk1,Xpot,D930020B18Rik 0.50 0.46 2.98
11 69570999 8.21 0 1055268 68747919 69803186 49
Myh10,Ndel1,Rnf222,Rpl26,Odf4,Arhgef15,Slc25a35,Rangrf,Pfas,Ctc1,Aurkb,2310047M10Rik,Tmem107,Vamp2,Per1,Hes7,Aloxe3,Alox12b,Alox8,Gucy2e, 
Cntrob,Trappc1,Kcnab3,Chd3,Cyb5d1,Naa38,Tmem88,Kdm6b,Dnah2,Efnb3,Wrap53,Trp53,Atp1b2,Shbg,Sat2,Fxr2,Sox15,Mpdu1,Cd68,Eif4a1,Senp3,Tnfsfm1
3,Tnfsf13,Tnfsf12,Polr2a,Slc35g3,Zbtb4,Chrnb1,Fgf11
0.45 0.45 2.55
17 34159865 9.25 0 1456751 34145616 35602366 86
H2-DMb2,H2-DMb1,Psmb9,Tap1,Psmb8,Tap2,H2-Ob,H2-Ab1,H2-Aa,H2-Eb1,H2-
Eb2,Btnl2,Btnl1,BC051142,Btnl4,Btnl6,Notch4,Gpsm3,Pbx2,Ager,Rnf5,Agpat1,Egfl8,Ppt2,Prrt1,Fkbpl,Atf6b,Tnxb,C4b,Cyp21a1,Stk19,Dxo,Skiv2l,Nelfe,Cfb,C2,
Zbtb12,Ehmt2,Slc44a4,Neu1,Hspa1b,Hspa1a,Hspa1l,Lsm2,Vars,Vwa7,Sapcd1,Msh5,Clic1,Ddah2,G6b,Ly6g6c,Ly6g6d,Ly6g6e,Ly6g6f,Abhd16a,Ly6g5c, 
Ly6g5b,Csnk2b,Gpank1,D17H6S53E,Apom,Bag6,Prrc2a,Aif1,Lst1,Ltb,Tnf,Lta,Nfkbil1,Atp6v1g2,Ddx39b,H2-D1,H2-Q1,H2-Q2,H2-Q4,H2-Q6,H2-Q7,H2-
Q10,Pou5f1,Tcf19,Cchcr1,Psors1c2,Cdsn,2300002M23Rik,Sfta2
0.38 0.74 3.16
 
 
Table 2: Pathogenicity analysis of variants at loci associated with elevated micronucleus levels. 
Mouse_genomic_location Nearest_gene Consequence Log_p_value GERP_Score Grantham_classification Grantham_score SIFT_class Lowest_SIFT_score EnsEMBL_VEP_class EnsEMBL_aa_change AA change Nuc change
chr8:33576360-33576360 Tex15 A>T 12.48026273 -1.05 radical 110 tolerated 0.4 downstream_gene_variant;missense_variant R/S R1939S A5817T
chr8:33268792-33268792 Wrn G>A 12.45662832 -3.07 radical 145 tolerated 0.3 missense_variant S/L S1021L C3062T
chr8:33557389-33557389 Tex15 A>C 12.43606688 3.19 radical 110 tolerated 0.44 NMD_transcript_variant;downstream_gene_variant;missense_variant S/R S160R A478C
chr8:33557366-33557366 Tex15 G>T 12.4319775 3.14 radical 205 tolerated 0.13 NMD_transcript_variant;downstream_gene_variant;missense_variant C/F C152F G455T
chr8:33546343-33546343 Tex15 C>G 12.42405548 3.56 non-conservative 60 deleterious;tolerated 0.02 NMD_transcript_variant;missense_variant A/G A94G C281G
chr17:34804124-34804124 Cyp21a1 A>G 8.239597012 0 non-conservative 64 deleterious 0.01 downstream_gene_variant;missense_variant;upstream_gene_variant V/A V71A T212C
chr17:34711526-34711526 Tnxb G>A 8.198665514 4.53 radical 125 deleterious;tolerated 0.05 missense_variant G/R G397R G1189A
chr17:34711722-34711722 Tnxb G>A 8.188940007 -9.05 conservative 29 deleterious 0.02 missense_variant R/H R462H G1385A
chr17:34713138-34713138 Tnxb T>A 8.185003889 -2.37 radical 113 tolerated 0.21 missense_variant L/Q L550Q T1649A
chr17:35161042-35161042 Prrc2a T>G 8.088956801 4.11 conservative 15 deleterious 0.02 downstream_gene_variant;missense_variant;upstream_gene_variant M/L M249L A745C
chr11:69236603-69236603 Gucy2e C>G 7.758017279 -9.38 radical 125 tolerated 0.46 missense_variant;upstream_gene_variant G/R G15R G43C
chr10:121667433-121667433 D930020B18Rik T>C 7.543972828 0.726 radical 155 tolerated 0.85 missense_variant F/S F75S T224C
chr11:69047870-69047870 Aurkb T>C 7.224042226 2.01 radical 155 tolerated 0.74 missense_variant;upstream_gene_variant F/S F45S T134C
chr11:69134001-69134001 Aloxe3 G>A 6.687629704 3.92 conservative 56 deleterious 0.01 NMD_transcript_variant;missense_variant;upstream_gene_variant G/S G341S G1021A
chr11:69107564-69107564 Per1 C>T 6.656511366 2.92 non-conservative 64 deleterious 0.01 downstream_gene_variant;missense_variant A/V A1014V C3041T
chr9:109061596-109061596 Atrip A>T 5.330403284 -0.969 radical 113 NMD_transcript_variant;downstream_gene_variant;missense_variant;synonymous_variant;upstream_gene_variant L/Q NA NA
chr9:109073661-109073661 Atrip T>A 5.271500634 0.625 radical 152 deleterious 0.03 NMD_transcript_variant;downstream_gene_variant;missense_variant;splice_region_variant;upstream_gene_variantD/V NA NA
chr9:109432436-109432436 Fbxw16 A>G 5.023943697 0 radical 155 tolerated 0.56 missense_variant F/S F454S T1361C
chr2:30174134-30174134 D2Wsu81e C>T 4.890540776 4.1 radical 125 tolerated 0.34 downstream_gene_variant;missense_variant G/R G373R G1117A
chr2:30174134-30174134 D2Wsu81e C>T 4.890540776 4.1 radical 125 tolerated 0.34 downstream_gene_variant;missense_variant G/R G373R G1117A
chr2:29702527-29702527 Rapgef1 G>T 4.806085521 1.45 conservative 24 deleterious;tolerated 0.02 NMD_transcript_variant;missense_variant Q/H Q510H G1530T
chr2:29702527-29702527 Rapgef1 G>T 4.806085521 1.45 conservative 24 deleterious;tolerated 0.02 NMD_transcript_variant;missense_variant Q/H Q510H G1530T
chr2:29788325-29788325 Coq4 G>T 4.571110541 0 radical 102 tolerated 0.32 NMD_transcript_variant;missense_variant;upstream_gene_variant R/L R14L G41T
chr9:109060491-109060491 Atrip T>G 3.712727076 0.625 conservative 15 deleterious;tolerated 0.03 NMD_transcript_variant;downstream_gene_variant;missense_variant;upstream_gene_variant M/L M688L A2062C
chr5:148288927-148288927 Mtus2 C>A 3.699186538 0 radical 110 NMD_transcript_variant;missense_variant;synonymous_variant S/R NA NA
chr5:148288935-148288935 Mtus2 T>C 3.692862836 0 radical 145 NMD_transcript_variant;missense_variant;synonymous_variant L/S NA NA
chr9:109058117-109058117 Trex1 G>C 3.215586866 -1.25 radical 125 tolerated 0.18 downstream_gene_variant;missense_variant R/G R269G C805G
D
Chromosome Position All.mice.(n=1379) Males.(n=677) Females.(n=702)
2 29991588 5.14 1.85 3.70
5 148775593 4.58 2.12 2.64
8 33138260 13.01 6.74 7.35
9 109064030 5.32 1.88 3.53
10 121477912 8.55 2.84 7.76
11 69550069 8.09 10.40 0.58
17 34732496 8.42 2.75 7.39
- Log P values
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